Cas no 1261644-49-8 (3-Cyano-5-fluorobenzenesulfonyl Chloride)
3-Cyano-5-fluorobenzenesulfonyl Chloride Chemical and Physical Properties
Names and Identifiers
-
- 3-CYANO-5-FLUOROBENZENE-1-SULFONYL CHLORIDE
- 3-CYANO-5-FLUOROBENZENESULFONYL CHLORIDE
- AB75584
- D80890
- EN300-365588
- MFCD18394025
- CS-0161079
- 1261644-49-8
- SCHEMBL16235968
- AKOS006336644
- BS-15105
- 3-CYANO-5-FLUOROBENZENE-1-SULFONYLCHLORIDE
- ZQEROTOETXELJU-UHFFFAOYSA-N
- SY222080
- 3-Cyano-5-fluorobenzenesulfonyl Chloride
-
- MDL: MFCD18394025
- Inchi: 1S/C7H3ClFNO2S/c8-13(11,12)7-2-5(4-10)1-6(9)3-7/h1-3H
- InChI Key: ZQEROTOETXELJU-UHFFFAOYSA-N
- SMILES: ClS(C1C=C(C=C(C#N)C=1)F)(=O)=O
Computed Properties
- Exact Mass: 218.9557054g/mol
- Monoisotopic Mass: 218.9557054g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 328
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.8
- Topological Polar Surface Area: 66.3
3-Cyano-5-fluorobenzenesulfonyl Chloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD01049677-250mg |
3-Cyano-5-fluorobenzene-1-sulfonyl chloride |
1261644-49-8 | 95% | 250mg |
¥142.0 | 2022-03-01 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD01049677-1g |
3-Cyano-5-fluorobenzene-1-sulfonyl chloride |
1261644-49-8 | 95% | 1g |
¥342.0 | 2022-03-01 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD01049677-5g |
3-Cyano-5-fluorobenzene-1-sulfonyl chloride |
1261644-49-8 | 95% | 5g |
¥1194.0 | 2022-03-01 | |
| TRC | C998720-10mg |
3-Cyano-5-fluorobenzenesulfonyl Chloride |
1261644-49-8 | 10mg |
$ 70.00 | 2022-06-06 | ||
| TRC | C998720-50mg |
3-Cyano-5-fluorobenzenesulfonyl Chloride |
1261644-49-8 | 50mg |
$ 230.00 | 2022-06-06 | ||
| TRC | C998720-100mg |
3-Cyano-5-fluorobenzenesulfonyl Chloride |
1261644-49-8 | 100mg |
$ 340.00 | 2022-06-06 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-PO882-50mg |
3-Cyano-5-fluorobenzenesulfonyl Chloride |
1261644-49-8 | 95% | 50mg |
55.0CNY | 2021-07-14 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-PO882-250mg |
3-Cyano-5-fluorobenzenesulfonyl Chloride |
1261644-49-8 | 95% | 250mg |
193CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-PO882-1g |
3-Cyano-5-fluorobenzenesulfonyl Chloride |
1261644-49-8 | 95% | 1g |
293.0CNY | 2021-07-14 | |
| abcr | AB547662-5 g |
3-Cyano-5-fluorobenzene-1-sulfonyl chloride, 95%; . |
1261644-49-8 | 95% | 5g |
€306.90 | 2023-07-11 |
3-Cyano-5-fluorobenzenesulfonyl Chloride Related Literature
-
Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
-
Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
-
Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
-
Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
-
P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
Additional information on 3-Cyano-5-fluorobenzenesulfonyl Chloride
3-Cyano-5-fluorobenzenesulfonyl Chloride (CAS 1261644-49-8): A Versatile Sulfonylating Reagent in Modern Organic Synthesis
In the realm of specialty chemicals and pharmaceutical intermediates, 3-Cyano-5-fluorobenzenesulfonyl Chloride (CAS 1261644-49-8) has emerged as a valuable building block for synthetic chemists. This fluorinated benzenesulfonyl derivative combines the electron-withdrawing properties of both cyano and fluoro substituents, making it particularly useful in nucleophilic substitution reactions and as a precursor for various sulfonamide compounds.
The molecular structure of 3-Cyano-5-fluorobenzenesulfonyl Chloride features a sulfonyl chloride functional group at position 1, with cyano and fluoro groups strategically positioned at the 3 and 5 positions respectively. This arrangement creates unique electronic properties that influence its reactivity in cross-coupling reactions and heterocycle formation, topics currently trending in medicinal chemistry research.
Recent applications of this compound have gained attention in the development of kinase inhibitors and PET radiotracers, addressing growing interest in targeted cancer therapies and diagnostic imaging agents. The fluorine atom in particular makes this compound valuable for isotope labeling studies, a hot topic in drug metabolism research.
From a synthetic perspective, 3-Cyano-5-fluorobenzenesulfonyl Chloride demonstrates excellent reactivity in amide bond formation and Suzuki-Miyaura coupling reactions. Its electron-deficient aromatic ring facilitates various nucleophilic aromatic substitutions, making it a versatile intermediate for constructing complex molecular architectures - a key requirement in modern fragment-based drug discovery approaches.
The compound's stability profile has been extensively studied, with research showing optimal storage conditions at 2-8°C under inert atmosphere. These handling characteristics align well with current industry standards for high-value synthetic intermediates, particularly those used in GMP manufacturing environments.
Market analysis indicates growing demand for fluorinated building blocks like 3-Cyano-5-fluorobenzenesulfonyl Chloride, driven by expanding applications in agrochemicals and electronic materials. The cyano group in particular offers additional functionalization opportunities, making this compound valuable for diversity-oriented synthesis strategies.
Recent patent literature reveals innovative uses of this sulfonyl chloride in developing protein degraders (PROTACs) and covalent inhibitors, two rapidly growing areas in drug discovery. The compound's ability to serve as both a linking group and pharmacophore component explains its increasing popularity among medicinal chemists.
Quality control of 3-Cyano-5-fluorobenzenesulfonyl Chloride typically involves HPLC purity analysis and NMR characterization, with commercial samples generally available at >98% purity. These specifications meet the rigorous requirements of pharmaceutical development pipelines and academic research laboratories.
The environmental fate and green chemistry aspects of this compound have gained attention, with research focusing on biodegradation pathways and waste minimization strategies during synthesis. These considerations address growing concerns about sustainable chemical manufacturing in the specialty chemicals sector.
Looking forward, 3-Cyano-5-fluorobenzenesulfonyl Chloride is poised to maintain its importance in structure-activity relationship studies and lead optimization campaigns. Its unique combination of fluorine substitution and sulfonyl chloride reactivity continues to enable innovative solutions in small molecule therapeutics development.
For researchers working with this compound, recent advances in flow chemistry techniques have demonstrated improved safety profiles and higher yields in sulfonamide formation reactions. These process improvements align with industry trends toward continuous manufacturing and automated synthesis platforms.
In analytical applications, derivatives of 3-Cyano-5-fluorobenzenesulfonyl Chloride have shown promise as chromatographic tags and mass spectrometry enhancers, addressing current needs in metabolomics and proteomics research. The compound's UV-active properties further enhance its utility in these applications.
As the chemical industry moves toward more structure-diverse libraries for screening, intermediates like 3-Cyano-5-fluorobenzenesulfonyl Chloride that enable rapid scaffold hopping and privileged structure incorporation will likely see sustained demand from both biotech startups and established pharma companies.
1261644-49-8 (3-Cyano-5-fluorobenzenesulfonyl Chloride) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)